Opioid Receptors and their Pharmacological Profiles

References

• Pert C. B., Snyder S. H. Opiate receptor: Demonstration in nervous tissue. Science 1973; 179: 1011–1014
   PubMed Web of Science ®Google Scholar
• Simon E. J., Hiller J. M., Edelman I. Stereospecific binding of the potent narcotic analgesic 3H-etorphin to rat brain homogenate. Proc. Nat. Acad. Sci. USA 1973; 70: 1947–1949
   PubMed Web of Science ®Google Scholar
• Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. 1973; 32: 317–329
   PubMedGoogle Scholar
• Stefano G. B., Kream R. M., Zukin R. S. Demonstration of stereospecific opiate binding in the nervous tissue of marine mollusc Mytilus edulis. Brain Res. 1980; 180: 440–445
   Google Scholar
• Weigent D. A., Carr D. J. J., Blalock J. E. Bidirectional communication between the neuroendocrine and immune systems. Ann. N. Y. Acad. Sci 1990; 579: 17–27
   PubMed Web of Science ®Google Scholar
• Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapetides from the brain with potent opiate agonist activity. Nature 1975; 258: 577–579
   PubMed Web of Science ®Google Scholar
• Höllt V. Opioid peptide genes: Structure and regulation. Neurobiology of Opioids. Springer Verlag, Berlin 1991
   Google Scholar
• Nemeroff C. B. Psychoneuroendocrinology: Current Concepts. The Upjohn Company, Michigan 1990
   Google Scholar
• Numa S. Opioid peptide precursors and their genes. The Peptides. Academic Press, London 1984; Vol 6
   Google Scholar
• Cox B. M., Goldstein A., Li C. H. Opioid activity of a peptide, beta-lipotropin-(61–91), derived from beta-Lipotropin. Proc. Nat. Acad. Sci. USA 1976; 73: 1821–1823
   PubMed Web of Science ®Google Scholar
• Goldstein A., Tachibana S., Lowney L., Hunkapiller M., Hood L. Dynorphin (1–13), an extraordinarily potent opioid peptide. Proc. Nat. Acad. Sci. USA 1979; 76: 6666–6670
   PubMed Web of Science ®Google Scholar
• Goldstein A., Fischli W., Lowney L. I., Hunkapiller M., Hood L. Porcine pituitary dynorphin: Complete amino acid sequence of biologically active heptadecapeptide. Proc. Nat. Acad. Sci. USA 1981; 78: 7219–7223
   PubMed Web of Science ®Google Scholar
• Fields H. L., Basbaum A. I. Endogenous pain control mechanisms. Textbook of Pain, P. D. Wall, R. Melzack. Churchill Livingstone, Melbourne 1989
   Google Scholar
• Hayes L. Opioid receptors and signal transduction. Trends in Pharmacol. Sci. 1988; 9: 309–311
   Google Scholar
• Portoghese P. S. A new concept on the mode of interaction of narcotic analgesics with receptors. J. Med. Chem. 1965; 8: 609–616
   PubMed Web of Science ®Google Scholar
• Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exptl. Ther. 1976; 197: 517–532
   PubMed Web of Science ®Google Scholar
• Gilbert P. E., Martin W. R. The effect of morphine and nalorphin-like drugs in the nondependent, morphine-dependent and cycylazocine-dependent chronic spinal dog. J. Pharmacol. Exptl. Ther. 1976; 198: 66–82
   PubMed Web of Science ®Google Scholar
• Sofuoglu M., Portoghese P. S., Takemori A. E. Differential antagonism of DSLET and DPDPE by novel delta opioid receptor antagonists. Eur. J. Pharmacol. 1990; 183: 2322
   Google Scholar
• Pliska V., Heiniger J., Müller-Lhotsky A., Pliska P., Ekberg B. Binding of oxytocin to uterine cells in vitro. J. Biol. Chem. 1986; 261: 16984–16989
   PubMed Web of Science ®Google Scholar
• Oka K., Kantrowitz J. D., Spector S. Isolation of morphine from toad skin. Proc. Nat. Acad. Sci. USA 1985; 82: 1852–1854
   PubMed Web of Science ®Google Scholar
• Goldstein A., Barrett R. W., James I. F., Lowney L. I., Weitz C. J., Knipmeyer L. L., Rapoport H. Morphine and other opiates from beef brain and adrenal. Proc. Nat. Acad. Sci. USA 1985; 72: 5203–5207
   Google Scholar
• Donnerer J., Oka K., Brossi A., Rice K. C., Spector S. Presence and formation of codeine and morphine in rat. Proc. Nat. Acad. Sci. USA 1986; 83: 4566–4567
   PubMed Web of Science ®Google Scholar
• Shimohigashi Y., Costa T., Pfeiffer A., Herz A., Kimura H., Stammer C. H. Phe-4-enkephalin analogs: Delta receptors in rat brain are different from those in mouse vas deferens. FEBS Letters 1987; 222: 71–74
   Google Scholar
• Shimohigashi Y., Takano Y., Kamiya H., Costa T., Herz A., Stammer C. H. A highly selective ligand for brain delta opiate receptors, a Phe-4-enkephalin analog, suppresses mu receptor-mediated thermal analgesia by morphine. FEBS Letters 1988; 233: 289–293
   Google Scholar
• Wolozin B. L., Pasternak G. W. Classification of multiple morphine and enkephalin binding sites in the central nervous tissue. Proc. Nat. Acad. Sci. USA 1981; 78: 6181–6185
   PubMed Web of Science ®Google Scholar
• Hazum E., Chang K. J., Cuatrecases P., Pasternak G. W. Naloxazone irreversibly inhibits the high affinity binding of 125I-D-Ala2-D-Leu5 enkephalin. Life Sci. 1981; 28: 2973–2979
   Google Scholar
• Lutz R. A., Cruciani R. A., Costa T., Munson P., Rodbard D. A very high affinity opioid binding site in rat brain: demonstration by computer modelling. Biochem. Biophys. Res. Commun. 1984; 122: 265–269
   Google Scholar
• Toll L., Keys C., Polsar W., Loew G. The use of computer analysis in describing multiple opiate receptors. Neuropeptides 1984; 5: 205–208
   Google Scholar
• Lutz R. A., Cruciani R. A., Munson P., Rodbard D. Mu-1: a very high affinity subtype of enkephalin binding sites in rat brain. Life Sci. 1985; 36: 2233–2238
   PubMed Web of Science ®Google Scholar
• Varfolomeev S. D., Zaitsev S. V., Kurochkin I. N., Porodenko N. V. The kinetics and mechanism of ligand-receptor interactions in the system of opiate receptors. Synaptic transmitters and receptors, S. Tucek. Academia, Praha 1987
   Google Scholar
• Goodman R. R., Adler B. A., Pasternak G. W. Regional differences in μ1-binding of [3H][D-Ala2D-Leu5] enkephalin: Comparisons of thalamus and cortex in rat. Neurosci. Lett. 1985; 59: 155–158
   Google Scholar
• Hahn E. F., Carroll-Buatti M., Pasternak G. W. Irreversible opiate agonist and antagonists: The 14-hydroxy-dihydromorphinone azines. J. Neurochem 1982; 2: 572–576
   Google Scholar
• Pasternak G. W., Childers S. R., Snyder S. H. Naloxone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro. J. Pharmacol. Exptl. Ther. 1980; 214: 455–462
   Google Scholar
• Ling G. S. F., Macleod J. M., Lee S., Lockhart S. H., Pasternak G. W. Separation of morphine analgesia from physical dependence. Science 1984; 226: 462–464
   Google Scholar
• Ling G. S. F., Spiegel K., Lockhart S. H., Pasternak G. W. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J. Pharmacol. Exptl. Ther. 1985; 232: 149–154
   PubMed Web of Science ®Google Scholar
• Cruciani R. A., Lutz R. A., Munson P. J., Rodbard D. Naloxonazine effects on the interaction of enkephalin analogs with mu1 mu and delta opioid binding sites in rat brain membranes. J. Pharmacol. Exptl. Ther. 1987; 242: 15–20
   Google Scholar
• Remmers A. E., Medzihradsky F. Reconstitution of high affinity opioid agonist binding in brain membranes, Proc. Nat. Acad. Sci. 1991; 88: 2171–2175
   Google Scholar
• Rothman R. B., Bowen W. D., Herkenham M., Jacobson A. E., Rice K. C., Pert C. B. A quantitative study of [3H][D-Ala2D-Leu5] enkephalin binding to rat brain membranes. Evidence that oxomorphine is a non-competitive inhibitor of the lower affinity delta-binding site. Mol. Pharmacol. 1985; 27: 399–409
   Google Scholar
• Rothman R. B., Long J. B., Bykov V., Jacobson A. E., Rice K. C., Holaday W. beta-FNA binds irreversibly to the opiate receptor complex: In Vivo and in Vitro Evidence. J. Pharmacol. Exptl. Ther. 1988; 247: 405–416
   PubMed Web of Science ®Google Scholar
• Zajac J. M., Roques B. P. Differences in Binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides. J. Neurochem 1985; 44: 1605–1614
   Google Scholar
• Frankhuijzen A. L., Wardeh G. W., Mulder A. H., Schoffelmneer A. N. M. Non-competitive interaction between mu and delta-opioid receptor binding sites in homogenates from the rat neocortex. Eur. J. Pharmacol. 1990; 183: 2307
   Google Scholar
• Jiang Q., Mosberg H. I., Porreca F. Modulation of the potency and efficacy of mu-mediated antinocioception by delta agonists in the mouse. J. Parmac. Exptl. Ther. 1990; 254: 683–689
   PubMedGoogle Scholar
• Chow T., Zukin R. S. Solubilisation and preliminary characterisation of mu and kappa opiate receptor subtypes from rat brain, Mol. Pharmacol. 1983; 24: 203–212
   Web of Science ®Google Scholar
• Itzhak Y., Hiller J. M., Simon E. J. Solubilisation and characterisation of mu, delta and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors, Proc. Nat. Acad. Sci. USA 1984; 81: 4217–4221
   PubMed Web of Science ®Google Scholar
• Cabon A., Cupo A., Ruiz-Gayo M., Baumann N. A., Zalc A. Pharmacological and molecular properties of opioid binding sites synthesized in a cell-free translation system. J. Neurosci. Res. 1990; 26: 242–250
   Google Scholar
• Loh H. H., Smith A. P. Molecular characterization of opioid receptors, Ann. Rev. Pharmacol. Toxicol 1990; 30: 123–147
   Google Scholar
• Ueda H., Satoh M. Mu-opioid receptor – purification and reconstitution with GTP-bindung protein. Receptor Purification 1990; 115–129
   Google Scholar
• Schwyzer R. Molecular mechanism of opioid receptor selection. Biochemistry 1986; 25: 6335–6342
   PubMed Web of Science ®Google Scholar
• Sagan S., Amiche M., Delfour A., Mor A., Camus A., Niucolas P. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin. J. Biol. Chem. 1989; 264: 17100–17106
   PubMed Web of Science ®Google Scholar
• Loew G., Hashimoto G., Williamson L., Burt S., Anderson W. Conformational energy studies of tetrapeptide opiates: Candidate active and inactive conformations. Mol. Pharmacol. 1982; 22: 667–677
   Google Scholar
• Loew G., Keys C., Luke B., Polgar W., Toll L. Stucture-activity studies of morphiceptin: receptor binding and molecular determinants of mu-affinity and selectivity. Mol. Pharmacol. 1986; 29: 546–553
   Google Scholar
• Lazarus L. H., Wilson W. E., Guglietta A., de Castiglione R. Dermorphin interaction with rat brain opioid receptors: involvement of hydrophobic sites in the binding domain. J. Pharmacol. Exp. Therap: Mol. Pharmacol. 1990; 37: 886–892
   Google Scholar
• Schwyzer R. New principle in QSAR, membrane requirements. J. Receptor Res. 1991; 11: 45–57
   PubMed Web of Science ®Google Scholar
• Schwyzer R. Chemical structure and biochemical activity in polypeptide hormones. Pure and Applied Chem. 1963; 6: 265
   Google Scholar
• Schwyzer R. Estimated conformation, orientation, and accumulation of dynorphin a-(1–13)-tridecapeptides on the surface of neutral lipid membranes. Biochemistry 1986; 25: 4281–4286
   PubMedGoogle Scholar
• Coy D. H., Kastin A. J., Walker M. J., McGivern R. F., Sandman C. A. Increased analgesic activities of a fluorinated and a dimeric analogue of D-Ala-2-methionine enkephalinamide, Biochem. Biophys. Res. Commun. 1978; 83: 977
   PubMedGoogle Scholar
• Hazum E., Chang K.-J., Leihton H. J., Lever O. W., Jr., Quatrecasas P. Increase biologic activity of dimers of oxymorphone and enkephalins: possible role of receptor crosslinking, Biochem. Biophys. Res. Commun. 1982; 104: 347
   PubMedGoogle Scholar
• Costa T., Shimohigashi Y., Krumins S. A., Munson P. J., Rodbard D. Dimeric pentapeptide enkephalin: a novel probe of delta opiate receptors. Life Sci. 1982; 31: 1625
   PubMedGoogle Scholar
• Shimohigashi Y., Costa T., Chen H. C., Rodbard D. Dimeric tetrapeptide enkephalins display extraordinary selectivity for the delta opioid receptor. Nature 1982; 297: 333
   Google Scholar
• Shimohigashi Y., Costa T., Matsura S., Chen H.-C., Rodbard D. Dimeric enkephalins display enhanced affinity and selectivity for the delta opioid receptor. Mol. Pharm. 1982; 21: 558–563
   PubMedGoogle Scholar
• Hahn E. F., Pasternak G. W. Naloxonazine, a potent long-lasting inhibitor of opiate binding sites. Life Sci. 1982; 31: 1385
   Google Scholar
• Erez M., Takemori A. E., Protoghese P. S. Narcotic antagonistic potency of bivalent ligands which contain beta-naltrexamine. Evidence for bridging between proximal recognition sites. J. Med. Chem. 1983; 25: 847
   Google Scholar
• Lutz R. A., Costa T., Shimohigashi Y., Rodbard D. Dimerization of enkephalin-tripeptides increases the affinity to rat brain membranes and NG108–15 cells. Fed. Proc. 1984; 43
   Google Scholar
• Lutz R. A., Cruciani R. A., Shimohigashi Y., Costa T., Kassis S., Munson P. J., Rodbard D. Increased affinity and selectivity of enkephalin tripeptide (Tyr-D-Ala-Gly) dimers. Eur. J. Pharmacol. 1985; 111: 257–261
   PubMedGoogle Scholar
• Shimohigashi Y., Kodama H., Costa T., Lutz R. A., Chen H.-C., Rodbard D. Binding characteristics of a series of dimeric tripeptide enkephalins for delta opiate receptors in rat brain and NG108–15 cells. J. Molecular Recogn. 1989; 2: 127–131
   Google Scholar
• Balboni G., Marastoni M., Picone D., Salvadori S., Tancredi T., Temussi P. A., Tomatis R. New features of the delta opioid receptor: conformational properties of deltorphin I analogues. Biochem. Biophys. Res. Commun. 1990; 169: 617–622
   Google Scholar
• Lutz R. A., Costa T., Cruciani R. A., Jacobson A. E., Rice K. C., Burke T. R., Jr., Krumins S. A., Rodbard D. Increased affinity of dimeric enkephalins is not dependent on receptor density. Neuropetides 1985; 6: 167–174
   PubMedGoogle Scholar
• Bourne H. R., Sanders D. A., McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990; 348: 125–132
   PubMed Web of Science ®Google Scholar
• Neer E. J., Clapham D. E. Roles of G protein subunits in transmembrane signalling. Nature 1988; 333: 129–134
   PubMed Web of Science ®Google Scholar
• Kelly M. J., Loose M. D., Ronneleiv O. K. Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance. Neuroendocrinology 1990; 52: 268–275
   PubMed Web of Science ®Google Scholar
• Miranda H. F., Paeile C. Minireview: Interactions between analgesics and calcium channel blockers. Gen. Pharmacol. 1990; 21: 171–174
   PubMedGoogle Scholar
• Pert C. B., Snyder S. H. Opiate receptor binding of agonists and antagonists affected differently by sodium. Mol. Pharmacol. 1974; 10: 868
   Web of Science ®Google Scholar
• Ott S., Costa T., Wuster M., Hietel B., Herz A. Target size analysis of opioid receptors: No difference between receptor types, but discrimination between two receptor states. Eur. J. Biochem. 1986; 155: 621
   Google Scholar
• Ott S., Costa T., Herz A. Sodium modulates opioid receptors through a membrane component different from G proteins. Demonstration by target size analysis. J. Biol. Chem. 1988; 263: 10524
   Google Scholar
• Tao P. L., Chang L. R., Lee H. K., Loh H. H. Determination of the sizes of the opioid receptors in their membrane environment by radiation inactivation. Proc. Natl. Sci. Counc., Repub. China, Part B: Life Sci. 1986; 10: 184
   Google Scholar
• Demoliou-Mason C. D., Barnard E. A. Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes. J. Neurochem. 1986; 46: 1118–1128
   Google Scholar
• Hammer R. P. Mu-opiate receptor binding in the medial preoptic area is cyclic and sexually dimorphic. Brain. Res. 1990; 515: 187–192
   Google Scholar
• Fekete M. I. K., Szentendrei T., Kiem D. T. Changes of GTP binding in hormone induced opiate or adrenergic subsensitivity. Eur. J. Pharmacol. 1990; 183: 2161
   Google Scholar
• Simon E. J. Multiple opioid receptors. Neurobiology of Opioids, O. F. X. Almeida, T. S. Shippenberg. Springer Verlag, Berlin 1991
   Google Scholar
• Herkenham M. Mismatches between neurotransmitter and receptor localisation in the brain: Observations and implications. Neuroscience 1987; 23: 1–38
   PubMed Web of Science ®Google Scholar
• Fuxe K., Agnati L. F., Zoli M., Cintra A., Härfstrand A., von Euler G., Grimaldi R., Kalia M., Eneroth P. The opioid peptide system: Their organisation and role in volume transmission and neuroendocrine regulation. Regulatory Roles of Opioid Peptides, P. Illes, C. Farsang. Verlagsgesellschaft, WeinheimGermany 1988
   Google Scholar
• Mansour A., Schafer M. K. -H., Newman S. W., Watson S. J. Central distribution of opioid receptors: A cross-species comparison of the multiple opioid system of the basal ganglia. Neurobiology of Opioids, O. F. X. Almeida, T. S. Shippenberg. Springer Verlag, Berlin 1991
   Google Scholar
• Hughes J. The dynorphin (kappa opioid) receptor. Regulatory Roles of Opioid Peptides, P. Illes, C. Farsang. Verlagsgesellschaft, WeinheimGermany 1988
   Google Scholar
• Hamilton M. E., Bozarth M. A. Feeding elicited by dynorphin (1–13) microinjection into the ventral tegmental area in rats. Life Sci. 1988; 43: 941–946
   PubMed Web of Science ®Google Scholar
• Hamilton M. E., Bozarth M. A. Kappa receptor mediation of VTA opioid-elicited feeding behavior. Soc. Neurosci. Abs. 1988; 14: 1157
   Google Scholar
• Mann P. E., Arjune D., Romero M.-T., Pasternak G. W., Hahn E. F., Bodnar R. J. Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine. Psychopharmacology (Berlin) 1988; 94: 336–341
   Google Scholar
• Gosnell B. A. Involvement of μ opioid receptors in amygdala in the control of feeding. Neuropharmacology 1988; 27: 319–326
   Google Scholar
• Gosnell B. A. Opioid injections into the bed nucleus of the stria terminalis: Effects on food intake, Soc. Neurosci. Abs. 1988; 14: 1106
   Google Scholar
• Klitenick M. A., Wirtshafter D. Studies on the effects of micro injections of various opiate peptides into the midbrain raphe nuclei or ventral tegmental area. Soc. Neurosci. Abs. 1988; 14: 294
   Google Scholar
• Teskey G. C., Kavaliers M. Effects of opiate agonists and antagonists on aggressive encounters and subsequent opioid-induced analgesia, activity and feeding response in male mice, Pharmacol. Biochem. and Beh. 1988; 31: 43–52
   Google Scholar
• Olson G. A., Olson R. D., Kastin A. J. Endogenous opiates: 1988. Peptides 1989; 10: 1253–1280
   Google Scholar